PTHL (ftzy.com.cn) Forward P/S Multiple

Pheton Holdings Ltd generates revenue through the implementation of radiotherapy software, while the deep integration of IT systems within clinics ensures subscription stability. The forward price-to-sales valuation reflects market expectations, with the 27.50 mark capturing this metric. The business's financial success relies on Chinese demand for brachytherapy equipment and the regular supply of isotopes.
PTHL (Pheton Holdings Limited): analytical breakdowns and indicator data

This indicator reflects the market value of the business relative to expected revenue, accounting for the cost of capital and allowing for an assessment of the risk of overpaying for future cash flows. By analyzing the forward P/S valuation, an investor can compare the current discount with the pace of Pheton Holdings Ltd (PTHL) restructuring and the implementation of transparent reporting standards, which should mitigate the risk of share write-downs amid changing interest rates.